Illumaxbio Technology
Wuhan, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A provider of high-performance recombinant antibodies and custom services for research and diagnostics.
Diagnostics
Technology Platform
Recombinant antibody generation platform for producing high-specificity antibodies for research, diagnostic, and therapeutic applications.
Opportunities
Growing demand for high-quality research reagents and diagnostic components from China's expanding biopharma and research sectors.
Risk Factors
Vulnerability to competition from large, diversified life science tools companies with vast sales networks and resources.
Competitive Landscape
Competes in the global research antibody and diagnostic component market, where price, specificity, and reliability are key differentiators.